Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Diaz-Santa J, Rodriguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, Arnan M, Vives S, Salamero O, Lloveras N, Bargay J, Sampol A, Cruz D, Garcia A, Quinones T, Esteve J, Sierra J, Gallardo D; on the behalf of CETLAM Group. UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy. Leukemia. 2020 Nov;34(11):2925-2933. doi: 10.1038/s41375-020-0784-2. Epub 2020 Mar 9. PubMed PMID: 32152464.
AÑO: 2020; IF: 11.528
32152464
Bravo-Perez C, de la Morena-Barrio ME, Palomo A, Entrena L, de la Morena-Barrio B, Padilla J, Minano A, Navarro E, Cifuentes R, Corral J, Vicente V. Genotype-phenotype gradient of SERPINC1 variants in a single family reveals a severe compound antithrombin deficiency in a dead embryo. Br J Haematol. 2020 Oct;191(1):e32-e35. doi: 10.1111/bjh.16963. Epub 2020 Jul 19. No abstract available. PubMed PMID: 32686144.
AÑO: 2020; IF: 6.998
32686144
Bauduer F, de la Morena-Barrio ME, Salloum-Asfar S, de la Morena-Barrio B, Padilla J, Minano A, Vicente V, Carbonell P, Corral J, Esteban J. When genetic and surname analyses meet historical sources: The C56R mutation associated with factor XI deficiency as a marker of human migration during the Spanish Reconquista. Med Hypotheses. 2020 Aug;141:109709. doi: 10.1016/j.mehy.2020.109709. Epub 2020 Apr 6. PubMed PMID: 32278893.
AÑO: 2020; IF: 1.538
32278893
Castanon E, Sanchez-Arraez A, Alvarez-Mancenido F, Jimenez-Fonseca P, Carmona-Bayonas A. Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings. Eur J Cancer. 2020 Sep;136:159-168. doi: 10.1016/j.ejca.2020.06.003. Epub 2020 Jul 19. Erratum In: Eur J Cancer. 2020 Nov 5;: PubMed PMID: 32698098.
AÑO: 2020; IF: 9.162
32698098
Camelo-Castillo A, Marin F, Roldan V. Factor XI, much more than an innocent observer. J Thromb Haemost. 2020 Dec;18(12):3172-3173. doi: 10.1111/jth.15093. No abstract available. PubMed PMID: 33467843.
AÑO: 2020; IF: 5.824
33467843
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL